Health Campaign Examples That Changed Women's Health Norms
Forgotten in research, women fought back to reshape their own medical care.

Advocacy for women's health arose not from a smoothly functioning system seeking minor adjustments. They started because the medical research behind women's care had left women out for decades. Taking shape during the 1960s and into the 1970s, the Women's Health Movement arose directly from condescending care, sex-based diagnostic prejudice, and physicians keeping essential medical details from their own patients. When the FDA issued a 1977 directive barring those who might become pregnant from initial drug studies, an entire cohort of therapies and clinical regimens reached patients having been evaluated almost exclusively in male subjects. Activists challenged exclusion using official routes. That year brought the creation of the Congressional Caucus dealing with Women's Issues, later NIH rules requiring inclusion, and the subsequent Office of Research focused on Women's Health, with each step directly answering documented exclusion rather than change offered on its own. By 1973, local women's health collectives and self-help groups numbered in the hundreds nationwide, laying the community groundwork that later public health campaigns could draw on. As institutions recognized women's health as research-worthy rather than secondary, campaigns gained credible footing for reshaping how individual women understood their own bodies.
How campaigns reframe a condition
Telling women that a disease exists seldom changes how they respond to it. Campaigns that changed behavior worked more precisely: they reset the boundaries of normality, opened space for women to speak, and made fear or discomfort seem worth answering sensibly. In the examples ahead, two recurring logics emerge. One pattern brings a hidden condition into view, helping women see that heart disease could be their own risk, or that menstrual stigma was medical rather than merely private. The other pattern makes contact with healthcare feel warranted, so screening, testing, or a doctor’s conversation no longer looks like panic but like plain good judgment.
These two operations produce different results: one brings a condition home as personally significant, the other makes pursuing care seem like plain common sense. Malaysia's breast cancer campaign, known as"Be Cancer Alert", was studied and researchers found that although women afterward felt far more susceptible to the disease, the practical obstacles to screening stayed essentially the same. More women knew about the disease. The barriers to mammography, including expense, travel, anxiety, and missed work, did not budge. That divide runs through everything ahead: awareness matters, yet a campaign ending there completes only half its work.
Heart disease and the Red Dress: making women's leading killer speakable
The Heart Truth succeeded by correcting a single mistaken assumption women held, namely that heart disease only affected men. NHLBI introduced the campaign during September 2002, making it the nation's first federally backed effort to help women understand their vulnerability to heart disease. Its central red dress emerged from nationwide sessions the agency held with female participants, revealing that most had no idea cardiovascular illness killed more of them than anything else. Rather than keeping the warning as a bare number, the dress turned it into something visible on a pin, a signboard, or a catwalk.
Aimed at females aged 40–60, the initiative relied on allied groups and business ties to stage Red Dress runway events plus comparable programs. Those initiatives carried an estimated worth of about $65 million from 2003 onward, and the emblem reached billions of items sold. Public recognition nearly doubled once the effort first began. Beyond shifting mindsets, females aware that cardiac illness kills more of them than anything else showed higher rates of working out and shedding pounds compared to those lacking that knowledge.
The gains, however, proved uneven. By February 2024, NHLBI conceded that the progress had faded unevenly, since women who are Black or Latina, along with younger women, still lagged in awareness, and it launched a fresh, narrower phase of the effort. Norm shifts don't happen once and for all; they fade unless efforts are refreshed and redirected toward groups the initial push overlooked.
Angelina Jolie's 2013 op-ed and the sudden mainstreaming of genetic cancer risk
One personal disclosure normalized BRCA testing more in weeks than extended clinical outreach had accomplished. Jolie’s May 14, 2013 New York Times essay “My Medical Choice” disclosed her BRCA1 genetic alteration, an 87% lifetime breast cancer risk, and her choice to undergo prophylactic bilateral mastectomy, introducing countless readers to hereditary cancer risk and BRCA testing for the first time.
Rates of genetic testing rose sharply once the op-ed ran, since Jolie's disclosure freed genetic testing from clinical obscurity, which had carried stigma and dread, and made it a step someone could pursue proactively and speak about openly.
That shift carried a price. Post-announcement, the frequency of mastectomies after BRCA testing declined, since many of those who began pursuing screening were inherently less likely to harbor the mutation. The added expense of those extra screenings was estimated to reach tens of millions. None of this means the editorial failed to achieve its purpose. Whenever a hidden health issue suddenly gains public attention, initial reactions often exceed what is needed before finding equilibrium, which mirrors this case: subsequent research documented durable growth in suitable genetic screening that did not trigger proportional jumps in avoidable operations, indicating the first wave of demand gradually stabilized at a more precise level.
Always #LikeAGirl and the reframing of menstrual stigma as a confidence issue
Always introduced its #LikeAGirl campaign in 2014, reshaping the public meaning of "like a girl" while framing periods through a binary idea of gender that excluded some menstruating people. For years, people used "like a girl" to mean someone was weak or incapable, and the ad set out to reverse that sense. Always instead tied its menstrual products to a puberty-stage confidence message for girls, moving the brand away from secrecy and shame.
The numbers show the size of that shift. The video drew upwards of 90 million views, with over a million people passing it along. Campaign Live reported that the UN honored Always in March 2015 for how the effort advanced female empowerment. Before it aired, saying something was done "like a girl" mostly sounded like an insult in everyday talk, yet the sentiment surrounding those words flipped to overwhelmingly positive once it ran. Viewed alongside the history of menstrual product ads, that reversal carries even more weight. Kotex ads from the start of the 20th century forward relied on euphemism, labeling pads "feminine hygiene," making concealment the goal, and using blue fluid rather than red to keep menstruation off screen. The #LikeAGirl effort deliberately flipped that entire legacy.
The reframing had a shape of its own, and that shape left certain people out. Critics have noted that the campaign doubled down on the idea of menstruation as uniquely feminine, a framing that creates genuine difficulties for transgender men, who may find that "#LikeAGirl"-branded products intensify gender dysphoria. The objection takes nothing away from what the campaign achieved, yet it also reveals that whenever a campaign claims a health experience for one group, it inevitably excludes anyone outside that boundary.
Menstrual Hygiene Day and the CDC's Hear Her campaign: institutionalizing the speakable
With institutional support behind a health issue, related campaigns can achieve a reach far beyond what any lone brand push or individual disclosure could manage. The Hygiene Day for menstruation is organized by WASH United, a Berlin-based nonprofit, takes place each year on May 28, and gathers individuals and many kinds of organizations around the same advocacy calendar. Since its 2014 launch, this observance has put anti-stigma menstruation messaging before over a billion people. A yearly date coordinated across countries does what a one-time campaign cannot: it brings menstruation onto the regular agendas of public bodies, state actors, and newsrooms instead of treating it as an issue that comes up only when a news event forces the discussion.
Hear Her, the CDC's initiative, relies on another institutional pathway yet drives toward that same consolidation. Begun in 2020, it seeks to highlight critical maternal symptoms across the perinatal period while improving how expecting or recovering mothers communicate with their clinicians. The initiative goes beyond simply alerting mothers to the risks of gestational emergencies. It validates a mother's intuition that something is off as medically relevant, urging clinicians to respond to those concerns. According to the CDC, most maternal fatalities across the United States could be avoided, but hundreds of women continue losing their lives to gestational complications annually. The campaign treats those deaths as breakdowns in dialogue rather than purely clinical shortcomings. This marks a departure from earlier framings, shifting attention away from the illness itself toward whose accounts clinicians actually trust.
The gap between attitude change and behavior change
What people believe and what they do about it are different outcomes, and when campaigns fall short, the failure usually happens in the space between the two. A 2022 study of Malaysia's breast cancer campaign, "Be Cancer Alert", offers a controlled view of where that divide emerges. In pre- and post-campaign surveys of women 40 and older, women's sense of personal vulnerability to breast cancer increased significantly. By contrast, screening benefits were already viewed positively prior to the campaign and remained so afterward, indicating the message strengthened an existing belief instead of forming a new one.
Views on what stood in the way of screening remained unchanged. While the effort altered how participants viewed their personal vulnerability, tangible hurdles like expense, availability, and scheduling continued to block them from actually getting screened. Those barriers also differed by ethnicity. Among the participants, Chinese women recorded notably reduced scores compared to their Malay counterparts, highlighting cultural and social influences that the initiative failed to target precisely.
At this point the essay's case gets sharper rather than falling apart. Every campaign reviewed so far worked by going beyond raising awareness. Around its message, the Heart Truth assembled a whole infrastructure of partners. Jolie's op-ed was paired with a direct action, immediately available: get tested. Hear Her changed which voices clinicians actually trust. Making a diagnosis socially acceptable matters, yet that alone falls short. The most successful efforts combined this legitimacy with structural support, easy next steps, or a clear change in whose authority mattered. Malaysia identified the false belief yet omitted any call to act, power transfer, or delivery route, leaving mindsets changed but conduct unchanged.
The consistent mechanics behind campaigns that moved behavior, not just attitudes
Across these cases, behavior shifted measurably rather than merely becoming more favorable when four design patterns were present. Each effort singled out the false belief at stake and tackled it head-on. They challenged the ideas that heart disease affected only men, people needed a diagnosis before seeking BRCA testing, being described "like a girl" meant weakness, and pregnancy made a woman's worry that something felt wrong easy to ignore. Each campaign turned attention into a simple next move, whether getting screened, pursuing BRCA testing, or talking with a clinician. Both efforts reshaped who gets to diagnose, since NHLBI's focus groups showed women minimizing their own risk while Hear Her prioritized patients' self-reported symptoms. Both campaigns channeled their messaging through platforms situated precisely at the heart of each specific prejudice. Runway events and item wrappers spread awareness of cardiac illness, an individual essay addressed inherited cancer, a widely shared clip tackled period embarrassment, and an internationally synchronized schedule confronted broader taboos around menstruation.
Malaysia's push lacks two or more of the four required pieces. Public sentiment shifted while actual practices stayed the same. Reframing creates the opening, yet only the trio of a designated step, reassigned power, and proper outreach channel carry people across.


